14-1.
Reduce or eliminate indigenous cases of vaccine-preventable diseases.
| | |
14-1. | |
Reduce or eliminate indigenous cases of vaccine-preventable diseases. |
Target and baseline:
|
Objective |
Reduction in Vaccine-Preventable Diseases |
1998 |
2010 |
|
Number of Cases |
|||
|
14-1a. |
Congenital rubella syndrome (children under age 1 year) |
7 |
0 |
|
14-1b. |
Diphtheria (persons under age 35 years) |
1 |
0 |
|
14-1c. |
Haemophilus influenzae |
163 |
0 |
|
14-1d. |
Hepatitis B (persons aged
|
945† |
9 |
|
14-1e. |
Measles (persons of all ages) |
74 |
0 |
|
14-1f. |
Mumps (persons of all ages) |
666 |
0 |
|
14-1g. |
Pertussis (children under
|
3,417 |
2,000 |
|
14-1h. |
Polio (wild-type virus) |
0 |
0 |
|
14-1i. |
Rubella (persons of all ages) |
364 |
0 |
|
14-1j. |
Tetanus (persons under age 35 years) |
14 |
0 |
|
14-1k. |
Varicella (chicken pox) |
4 million‡ |
400,000 |
*Includes cases with type b and unknown serotype.
†Estimated hepatitis B cases for 1997.[26]
‡Data based on average from 1990–94 for persons of all
ages.
Target setting method: Total elimination for congenital rubella syndrome, diphtheria, Haemophilus influenzae type b, measles, mumps, polio, rubella, and tetanus; 41 percent improvement for pertussis; 99 percent improvement for hepatitis B; and 99 percent improvement for varicella.
Data sources: National Notifiable Disease Surveillance System (NNDSS), CDC, EPO; National Congenital Rubella Syndrome Registry (NCRSR), CDC, NIP—congenital rubella syndrome; Active Bacterial Core Surveillance (ABCs), Emerging Infections Programs, CDC, NCID—Haemophilus influenzae type b; National Health Interview Survey (NHIS), CDC, NCHS—varicella.